Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a new chief executive, who highlighted the “urgency” of the moment.
https://www.nytimes.com/2025/07/29/business/ozempic-novo-nordisk-stock-plunge.html